Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving... Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving veterinarians, farmers, and pet owners in over 100 countries. Virbac develops, manufactures, and markets a comprehensive portfolio of products, including vaccines, antibiotics, parasiticides, dental care items, nutritional supplements, diagnostics, anti-inflammatory, and dermatological treatments. These solutions are designed to address a wide range of health needs for both companion animals and livestock. Notably, Virbac invests heavily in research and development, consistently introducing innovative therapies—such as recent antimicrobial-free treatments for canine conditions and licensed therapeutic antibodies for canine diseases—to improve animal well-being. Headquartered in Carros Cedex, France, Virbac operates manufacturing and R&D centers worldwide and stands as the world’s sixth largest veterinary biopharma group, recognized for its independent ethos and commitment to advancing global animal health.
In 2024, Virbac was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Virbac has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Virbac are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
6.5 CCM/CCA - Transport by motorbikes, passenger cars and light commercial vehicles
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
c
0000000
7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Virbac’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to 2021.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Virbac’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Virbac’s data sources below and access millions more through our Disclosure Search.
a. Virbac's Annual Report 2024
b. Virbac's Non-financial report 2023
c. Virbac's Non-financial report 2022
Insights into Virbac's Revenues from Sustainable Activities
In 2024, Virbac reported EU Taxonomy-eligible revenues of EUR 811.60 million, representing 58.1% of its total turnover. Of this amount, EUR 0 of Virbac's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Insights into Virbac's CAPEX from Sustainable Activities
In 2024, Virbac reported EU Taxonomy-eligible CAPEX of EUR 85.20 million,representing 22.1% of its total CAPEX. Of this amount, EUR 0 of Virbac's CAPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Virbac's Taxonomy-Eligible Capex Over Time
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
Have Virbac's increased its investment in sustainable activities over time?
Compared to the previous year (2023), Virbac's taxonomy-aligned CAPEX decreased by 100%,suggesting that Virbac may have scaled back investments in sustainable projects, reprioritized its capital deployment, or reduced transparency in its taxonomy-aligned disclosures.a, b
Insights into Virbac's OPEX from Sustainable Activities
In 2024, Virbac reported EU Taxonomy-eligible OPEX of EUR 0,representing 0% of its total operating expenses (OPEX). Of this amount, EUR 0 of Virbac's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
b
b
a
b
c
c
b
c
a
b
c
c